Basic Contiflo Information

• INN (International Nonproprietary Name): Tamsulosin.
• Brand Names Available In United Kingdom: Flomax Relief; Cositam XL appears in UK/EU listings; other global brand names include Flomax, Losinate MR, Omsula MR, Tamfrex XL, Tamsumac MR and Tamurex MR (note: Vesomni and Combodart are combination products containing other active ingredients).
• ATC Code: G04CA02.
• Forms & Dosages: Capsule (hard) 0.4 mg; modified‑release tablet/capsule 0.4 mg is also marketed in some areas.
• Manufacturers In United Kingdom: Originator and major suppliers include Boehringer Ingelheim; generics and licensed suppliers include Astellas Pharma, Teva and Sandoz.
• Registration Status In United Kingdom: Tamsulosin products are authorised in the UK; Flomax Relief is supplied as a pharmacy (P) medicine with pharmacist oversight under MHRA arrangements.
• OTC / Rx Classification: Prescription (Rx) only in most markets; pharmacy‑only (P) supply for Flomax Relief in the UK.

Critical Warnings & Restrictions (Safety-First)

Tamsulosin is intended for adult men with symptomatic benign prostatic hyperplasia (BPH) and is not for use in children or in pregnant people.

People with a documented hypersensitivity to tamsulosin, including angioedema or severe cutaneous reactions, must not take it.

Severe hepatic insufficiency is a contraindication to use; moderate hepatic impairment requires caution.

Data are limited in severe renal impairment, so prescribers should exercise caution and monitor clinically when kidney function is poor.

The elderly do not routinely require a lower starting dose, but they have a higher risk of orthostatic hypotension and should have blood pressure monitored after initiation and after dose changes.

Before supply, use this simple checklist: baseline blood pressure, complete medication review for interacting drugs, and ask about recent or planned cataract surgery because of an ocular risk.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Older patients need extra monitoring for dizziness and postural hypotension, particularly during the first days of therapy.

Pregnancy and women of childbearing potential are not an intended population; the product is for adult men with BPH.

People with significant liver disease must not take tamsulosin if they have severe insufficiency, and moderate impairment needs cautious use.

Chronic illness such as uncontrolled cardiovascular disease or autonomic dysfunction increases the risk of symptomatic hypotension and requires clinician review.

Interaction With Activities (Driving, Workplace Safety Under UK Law)

Starting tamsulosin can cause dizziness or fainting in some people, especially after the first dose.

Avoid sudden standing from sitting or lying down and rise slowly to reduce the risk of orthostatic symptoms.

Be cautious with manual work, working at height, or tasks requiring full alertness during the first few days and after dose changes.

If you experience dizziness, fainting or blurred vision, stop driving and report it to your prescriber and pharmacist as required under UK safety guidance.

Q&A — “Can I Drive After Taking It In The UK?”

Short answer: generally yes if you feel well and are free of dizziness or visual disturbance.

Risks: first‑dose dizziness, orthostatic hypotension, fainting and blurred vision.

• Checklist — What To Do If Symptomatic: stop driving immediately, sit or lie down until symptoms pass, contact your prescriber or pharmacist, and report the event via the MHRA Yellow Card scheme if appropriate.
• Checklist — When To Inform DVLA: if a reaction causes persistent impairment that affects your fitness to drive, follow DVLA guidance and seek medical advice.

Usage Basics

INN And Brand Names Available In The UK

The International Nonproprietary Name is tamsulosin and the 0.4 mg dose is the standard preparation used for BPH treatment.

On the UK market, Flomax Relief is available as a pharmacy (P) medicine supplied with pharmacist oversight.

Cositam XL and other modified‑release (MR) preparations are also distributed in the UK and EU under different brand names.

Internationally, the medicine appears as Flomax, Cositam XL, Losinate MR, Omsula MR and similar names depending on the manufacturer and formulation.

Search terms commonly used by patients include tamsulosin capsules, tamsulosin MR and tamsulosin 400 microgram capsules when looking for product information or supplies.

Legal Classification (POM, P, GSL)

In most countries tamsulosin is prescription‑only (POM); however, Flomax Relief is a pharmacy (P)‑classified product in the UK.

Pharmacy‑only supply means a pharmacist must assess suitability before supply and provide counselling on risks such as hypotension and interactions.

• Table: POM Versus P Availability — POM: prescription required in most markets; P: Flomax Relief in UK pharmacy supply with pharmacist oversight.
• Major UK Suppliers: Boots, LloydsPharmacy, Superdrug commonly stock or can order tamsulosin products or provide clinical advice.

Dosing Guide

Standard Regimens (NHS‑Aligned)

The usual starting and maintenance dose for symptomatic BPH is 0.4 mg once daily taken after the same meal each day to reduce variability and dizziness.

Many patients notice symptom improvement within days to weeks, though full benefit may take several weeks and continued daily use is common for long‑term management.

Patients should take tamsulosin at the same time each day and avoid missing doses where possible to maintain steady symptom control.

Adjustments For Comorbidities

Elderly patients do not routinely require dose reduction, but they should have increased monitoring for hypotension after starting or changing dose.

Renal impairment: no dose change is required in mild to moderate impairment; in severe renal impairment caution is advised due to limited data.

Hepatic impairment: the drug is contraindicated in severe hepatic insufficiency and should be used cautiously in moderate dysfunction.

Children: tamsulosin is not recommended — safety and efficacy are not established in paediatric patients.

Q&A — “What If I Miss A Dose?”

If you miss a dose, take it as soon as you remember unless the next scheduled dose is close, in which case skip the missed dose and continue as normal.

Do not double up to make up a missed dose and contact your pharmacist or prescriber if repeated missed doses are a problem.

• Dosage Table Example — Condition: BPH → Dose: 0.4 mg once daily after the same meal.
• Initiation Monitoring Checklist — Baseline blood pressure, ask about dizziness, review ocular surgery history (cataract) before supply.

Interaction Chart

Food And Drinks (Alcohol, Tea/Coffee, Diet Habits)

Alcohol can increase the risk of hypotension and dizziness when combined with tamsulosin, so limit intake while starting treatment.

Caffeine (tea/coffee) has no specific major pharmacokinetic interaction, but stimulant effects and dehydration may worsen symptomatic tolerance to hypotension.

Take tamsulosin after the same meal each day to help reduce fluctuations in absorption and reduce dizziness risk.

Common Drug Conflicts (MHRA Yellow Card Data)

Concomitant use of strong CYP3A4 inhibitors such as ketoconazole and some macrolide antibiotics can raise tamsulosin exposure and requires caution.

Combining tamsulosin with other antihypertensives or with PDE‑5 inhibitors can cause additive blood pressure‑lowering effects and increase dizziness risk.

Using two alpha‑blockers together increases orthostatic hypotension risk and is generally avoided without specialist advice.

• Interaction Table — Drug: Ketoconazole → Effect: Increased tamsulosin levels → Action: Use caution; consider dose review or alternative.
• Interaction Table — Drug: PDE‑5 Inhibitors → Effect: Additive hypotension → Action: Monitor blood pressure; advise caution when used together.
• Recommendation: Check MHRA Yellow Card reports for any emerging safety signals.

User Reports & Trends (UK Patient Perspective)

Patients in the UK commonly report improved urinary flow and fewer nocturia episodes within days to weeks of starting tamsulosin.

Typical side‑effects reported on forums and by NHS patient information include initial dizziness, nasal congestion and ejaculatory disturbance or reduced semen.

Users frequently search for tamsulosin for prostate symptoms, tamsulosin capsules and tamsulosin modified release options like Contiflo XL or Cositam XL.

Many patients consult a pharmacist before trying Flomax Relief because it is available as a pharmacy medicine and offers quicker access than a GP appointment.

• Reported Benefits: improved urine flow, reduced urinary urgency, reduced nocturia.
• Reported Side Effects: dizziness, nasal congestion, ejaculation problems, occasional headache.

Time‑to‑effect Versus Discontinuation Reasons — symptom relief often appears in days–weeks; common discontinuation reasons include troublesome dizziness or sexual side‑effects.

For balanced information, patients are advised to consult NHS and Patient.info pages alongside pharmacist advice.

Access & Purchase Options (UK)

High‑Street Pharmacies (Boots, LloydsPharmacy, Superdrug)

Flomax Relief is sold as a pharmacy (P) medicine in the UK and can be supplied after a pharmacist assessment in high‑street chains and community pharmacies.

Many other tamsulosin brands remain prescription‑only and require a GP or hospital prescription for supply.

Community pharmacists can provide counselling, check for contraindications and interactions, and advise on monitoring for hypotension and ocular surgery issues.

Online Pharmacies And NHS E‑Prescriptions

Licensed online pharmacies in the UK handle electronic prescriptions routinely, and some allow a remote consultation to assess suitability for a pharmacy‑only product.

Always verify GPhC registration and check packaging and manufacturer details such as Boehringer Ingelheim, Teva or Sandoz to ensure authenticity.

Purchase Note: In our online pharmacy, contiflo is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

• Checklist For Safe Online Purchase: check GPhC registration, require prescription where applicable, verify authentic manufacturer packaging on delivery.

Mechanism & Pharmacology

Simplified Explanation

Tamsulosin is an alpha‑1 adrenoceptor antagonist with relative selectivity for the prostatic alpha‑1A receptor subtype, which relaxes smooth muscle in the prostate and bladder neck.

This relaxation reduces urethral resistance and improves urinary flow in men with BPH without reducing prostate size.

The drug is classified under ATC code G04CA02 as an alpha‑adrenoreceptor antagonist for urological use.

Clinical Terms

Typical formulations include 0.4 mg hard capsules and modified‑release tablets in some markets.

Metabolism is hepatic, so CYP‑mediated interactions are clinically relevant, particularly with strong CYP3A4 inhibitors.

Onset of symptomatic relief is usually within days to weeks, and there is no evidence that tamsulosin reduces prostate volume; benefits are symptomatic rather than structural.

• Definition List: Mechanism — alpha‑1A blockade; ATC — G04CA02; Formulations — 0.4 mg capsules, MR tablets.

Indications & Off‑Label Uses

MHRA‑Approved Uses

MHRA‑approved primary indication is symptomatic treatment of benign prostatic hyperplasia to improve urine flow and reduce obstructive urinary symptoms.

The recommended standard dosage for BPH is 0.4 mg once daily after the same meal.

Off‑Label Practices In NHS And Private Care

Off‑label uses include medical expulsive therapy for some ureteric stones where clinicians may prescribe 0.4 mg once daily for a tailored short course.

Evidence for this off‑label use varies and duration is determined case‑by‑case by the treating clinician.

• Indications Versus Off‑Label: BPH — approved; Kidney stone passage — occasional off‑label use at 0.4 mg daily.
• Pros For Kidney‑Stone Use: may aid stone passage for distal ureteric stones; Cons: variable evidence and off‑label status requires informed consent.

Key Clinical Findings (UK & EU Context)

Randomised and observational data show tamsulosin provides symptomatic relief for lower urinary tract symptoms due to BPH, typically within days to weeks of starting therapy.

Common adverse events include dizziness, nasal congestion and ejaculatory disturbance and these should be discussed before initiating treatment.

Orthostatic hypotension is a recognised risk, particularly at the start of treatment and in older patients, and blood pressure monitoring is recommended.

There is an important ophthalmic safety point: patients should notify their eye surgeon before cataract surgery because of the risk of intraoperative floppy iris syndrome.

• Clinical Takeaways: Benefit — improved flow; Onset — days–weeks; Common Adverse Events — dizziness, ejaculation problems, hypotension.

Safety reporting should be made via the MHRA Yellow Card scheme for suspected adverse reactions.

Alternatives Matrix

NHS Prescribing Alternatives (Comparison Table)

Pros And Cons Checklist

• Alpha‑blockers act quickly but may cause orthostatic hypotension and ejaculatory side effects.
• 5‑alpha‑reductase inhibitors reduce prostate size over months and carry sexual side effects but lower long‑term progression risk.
• Shared decision‑making should consider speed of relief, prostate size goals, comorbidities and patient preference.

Common Questions (Patient Consultations)

“Will it affect sex life?” — Tamsulosin can cause ejaculation problems such as reduced or absent semen and this should be discussed before starting.

“How long before I feel better?” — Many patients notice relief in days to weeks; if no improvement after 4–8 weeks, review with the prescriber is reasonable.

“Should I tell my eye surgeon?” — Yes; inform any ophthalmic team before cataract surgery due to the risk of intraoperative floppy iris syndrome.

“What are emergency signs?” — Seek immediate care for syncope, priapism or signs of severe allergic reaction such as swelling of the face or throat.

• Who To Contact: GP or urology clinic for ongoing concerns; pharmacist for medicine queries; A&E for emergencies such as syncope or priapism.
• Reporting: report suspected adverse reactions via the MHRA Yellow Card scheme.

NHS Cost & Access Comparison Table

Prescription charges and arrangements vary across UK nations; this influences whether patients obtain tamsulosin on an NHS prescription or via pharmacy supply.

Practical Tip: use the NHS Electronic Prescription Service for repeat prescriptions and check eligibility for free prescriptions in your UK nation.

Registration & Regulation

MHRA Approval Process (UK)

Tamsulosin products are authorised nationally and through EU pathways with packaging and branding varying by licence and manufacturer.

Flomax Relief is supplied as a pharmacy medicine in the UK under MHRA oversight and originator and generic manufacturers include Boehringer Ingelheim, Astellas, Teva and Sandoz.

NHS Prescribing Framework

Prescribers should follow local formularies and community pharmacists must screen for contraindications, interactions and counsel on risks such as hypotension and cataract surgery implications.

Suspected adverse reactions should be reported to the MHRA Yellow Card scheme to support ongoing pharmacovigilance.

• Definition List — MHRA Role: product authorisation and safety oversight; NHS Formulary: local prescribing guidance; Yellow Card: adverse event reporting.
• Checklist For Formulary Compliance: confirm indication, check interactions, counsel patient on blood pressure monitoring and ocular surgery notification.

Storage & Handling

UK Household Storage (Cold/Damp Climate Considerations)

Store tamsulosin between 20–25°C and protect it from moisture and heat to preserve stability.

Keep medicines in their original packaging and avoid storing them in bathrooms where humidity fluctuates.

Do not freeze tamsulosin products and check blister integrity before use.

Guidance From NHS And Pharmacists

Keep all medicines out of the reach of children and check expiry dates before taking or supplying medicines.

Return unused or expired medicines to a pharmacy for safe disposal rather than throwing them in household waste.

• Transport Checklist: keep in original packaging, protect from moisture, do not leave in direct sunlight or freezing conditions.

Guidelines For Proper Use (Pharmacist Counselling & NHS Safety Advice)

UK Pharmacist Counselling Style

Key counselling points include taking 0.4 mg after the same meal each day and warning about dizziness and orthostatic hypotension particularly on initiation.

Pharmacists should discuss potential sexual side effects such as ejaculation changes and advise patients to inform ophthalmology teams before cataract surgery.

Concomitant medications such as strong CYP3A4 inhibitors and other antihypertensives should be reviewed and documented during supply.

NHS Patient Safety Advice (Monitoring & Reporting)

Recommend a baseline blood pressure check and review within a few weeks of initiation in elderly patients, then periodic medication review annually or as clinically needed.

Encourage patients to report suspected adverse events via the MHRA Yellow Card and to contact GP or NHS 111 for urgent concerns such as priapism or severe syncope.

• Counselling Checklist: confirm indication, advise about timing with food, discuss dizziness and sexual effects, check interactions.
• Patient Handout Template: when to seek help, how to report side effects, contact details for GP and local pharmacy.

Delivery Across United Kingdom